Form 10-Q
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2007

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-9810

 


Owens & Minor, Inc.

(Exact name of Registrant as specified in its charter)

 


 

Virginia   54-1701843

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

9120 Lockwood Boulevard, Mechanicsville, Virginia   23116
(Address of principal executive offices)   (Zip Code)

 

Post Office Box 27626, Richmond, Virginia   23261-7626
(Mailing address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (804) 723-7000

 


Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b.2 of the Exchange Act).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The number of shares of Owens & Minor, Inc.’s common stock outstanding as of July 29, 2007, was 40,674,945 shares.

 



Table of Contents

Owens & Minor, Inc. and Subsidiaries

Index

 

               Page
Part I.    Financial Information   
  

Item 1.

  Financial Statements    3
     Condensed Consolidated Statements of Income – Three Months and Six Months Ended June 30, 2007 and 2006    3
     Condensed Consolidated Balance Sheets – June 30, 2007 and December 31, 2006    4
     Condensed Consolidated Statements of Cash Flows – Six Months Ended June 30, 2007 and 2006    5
     Notes to Condensed Consolidated Financial Statements    6
  

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    11
  

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk    16
  

Item 4.

  Controls and Procedures    16
Part II.    Other Information   
  

Item 1.

  Legal Proceedings    17
  

Item 1A.

  Certain Risk Factors    17
  

Item 4.

  Submission of Matters to a Vote of Shareholders    17
  

Item 6.

  Exhibits    18

 

2


Table of Contents

Part I. Financial Information

 

Item 1. Financial Statements

Owens & Minor, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(unaudited)

 

(in thousands, except per share data)    Three Months Ended
June 30,
   

Six Months Ended

June 30,

 
   2007     2006     2007     2006  

Revenue

   $ 1,679,044     $ 1,300,315     $ 3,365,243     $ 2,562,314  

Cost of revenue

     1,502,181       1,159,086       3,013,719       2,284,895  
                                

Gross margin

     176,863       141,229       351,524       277,419  

Selling, general and administrative expenses

     133,456       105,488       276,238       207,039  

Depreciation and amortization

     8,088       5,527       16,266       10,660  

Other operating income and expense, net

     (1,388 )     (1,012 )     (2,470 )     (1,932 )
                                

Operating earnings

     36,707       31,226       61,490       61,652  

Interest expense, net

     6,613       2,346       13,784       5,403  

Loss on early extinguishment of debt

     —         11,411       —         11,411  
                                

Income before income taxes

     30,094       17,469       47,706       44,838  

Income tax provision

     11,828       6,980       18,625       17,846  
                                

Net income

   $ 18,266     $ 10,489     $ 29,081     $ 26,992  
                                

Net income per common share – basic

   $ 0.45     $ 0.26     $ 0.73     $ 0.68  
                                

Net income per common share – diluted

   $ 0.45     $ 0.26     $ 0.71     $ 0.67  
                                

Cash dividends per common share

   $ 0.17     $ 0.15     $ 0.34     $ 0.30  
                                

See accompanying notes to condensed consolidated financial statements.

 

3


Table of Contents

Owens & Minor, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(unaudited)

 

(in thousands, except per share data)    June 30,
2007
    December 31,
2006
 

Assets

    

Current assets

    

Cash and cash equivalents

   $ 4,408     $ 5,090  

Accounts and notes receivable, net of allowances of $29,605 and $24,860

     515,496       539,178  

Merchandise inventories

     635,297       666,527  

Other current assets

     70,453       55,975  
                

Total current assets

     1,225,654       1,266,770  

Property and equipment, net of accumulated depreciation of $69,685 and $64,527

     71,745       70,853  

Goodwill, net

     259,041       259,670  

Intangible assets, net

     46,481       52,763  

Other assets, net

     37,544       35,694  
                

Total assets

   $ 1,640,465     $ 1,685,750  
                

Liabilities and shareholders’ equity

    

Current liabilities

    

Accounts payable

   $ 540,390     $ 542,552  

Accrued payroll and related liabilities

     12,143       13,472  

Other accrued liabilities

     90,916       114,479  
                

Total current liabilities

     643,449       670,503  

Long-term debt

     369,031       433,133  

Other liabilities

     54,483       34,660  
                

Total liabilities

     1,066,963       1,138,296  
                

Shareholders’ equity

    

Preferred stock, par value $100 per share; authorized—10,000 shares Series A; Participating Cumulative Preferred Stock; none issued

     —         —    

Common stock, par value $2 per share; authorized—200,000 shares; issued and outstanding – 40,636 shares and 40,257 shares

     81,273       80,515  

Paid-in capital

     152,731       143,557  

Retained earnings

     348,155       332,013  

Accumulated other comprehensive loss

     (8,657 )     (8,631 )
                

Total shareholders’ equity

     573,502       547,454  
                

Total liabilities and shareholders’ equity

   $ 1,640,465     $ 1,685,750  
                

See accompanying notes to condensed consolidated financial statements.

 

4


Table of Contents

Owens & Minor, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(unaudited)

 

(in thousands)    Six Months Ended
June 30,
 
   2007     2006  

Operating activities

    

Net income

   $ 29,081     $ 26,992  

Adjustments to reconcile net income to cash provided by (used for) operating activities:

    

Depreciation and amortization

     16,266       10,660  

Amortization of direct-response advertising

     3,501       1,219  

Loss on early extinguishment of debt

     —         11,411  

Provision for LIFO reserve

     5,900       5,070  

Share-based compensation expense

     3,804       2,945  

Provision for losses on accounts and notes receivable

     10,503       4,535  

Deferred direct-response advertising costs

     (4,391 )     (4,842 )

Changes in operating assets and liabilities:

    

Accounts and notes receivable

     13,179       (28,184 )

Merchandise inventories

     26,591       (35,320 )

Accounts payable

     1,838       59,811  

Net change in other current assets and liabilities

     (19,110 )     (12,249 )

Other, net

     (776 )     22  
                

Cash provided by operating activities

     86,386       42,070  
                

Investing activities

    

Additions to property and equipment

     (8,207 )     (8,286 )

Additions to computer software

     (4,842 )     (2,869 )

Acquisition of intangible assets

     (58 )     (2,090 )

Net cash paid for acquisitions of businesses

     (2,410 )     (3,721 )

Other, net

     375       (493 )
                

Cash used for investing activities

     (15,142 )     (17,459 )
                

Financing activities

    

Net proceeds of issuance of long-term debt

     —         198,134  

Repayment of long-term debt

     —         (210,449 )

Cash dividends paid

     (13,766 )     (12,024 )

Net payments on revolving credit facility

     (59,800 )     —    

Proceeds from exercise of stock options

     4,668       2,924  

Excess tax benefits related to share-based compensation

     2,076       1,221  

Decrease in drafts payable

     (4,000 )     (4,500 )

Other, net

     (1,104 )     2,290  
                

Cash used for financing activities

     (71,926 )     (22,404 )
                

Net increase (decrease) in cash and cash equivalents

     (682 )     2,207  

Cash and cash equivalents at beginning of period

     5,090       71,897  
                

Cash and cash equivalents at end of period

   $ 4,408     $ 74,104  
                

See accompanying notes to condensed consolidated financial statements.

 

5


Table of Contents

Owens & Minor, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(unaudited)

 

1. Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (which are comprised only of normal recurring accruals and the use of estimates) necessary to present fairly the consolidated financial position of Owens & Minor, Inc. and its wholly-owned subsidiaries (O&M or the company) as of June 30, 2007 and December 31, 2006, and the consolidated results of operations for the three- and six-month periods and cash flows for the six-month periods ended June 30, 2007 and 2006, in conformity with U.S. generally accepted accounting principles.

 

2. Interim Results of Operations

The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

 

3. Reclassifications and Corrections

Amortization of direct-response advertising costs is included in selling, general and administrative expenses. This expense was previously included in depreciation and amortization. All prior period amounts have been reclassified in order to conform to the current period presentation. This reclassification has no effect on revenue or net income as previously reported.

On December 31, 2006, the company adopted Statement of Financial Accounting Standard No. (SFAS) 158, which requires the company to recognize the funded status (i.e., the difference between the fair value of plan assets and the projected benefit obligations) of its benefit plans in its December 31, 2006 consolidated balance sheet, with a corresponding adjustment to accumulated other comprehensive income. The company incorrectly included the adjustment at adoption of $5.1 million ($3.1 million, net of tax) as part of comprehensive income for 2006 rather than as a direct adjustment to accumulated other comprehensive income in the company’s Annual Report on Form 10-K for the year ended December 31, 2006. Comprehensive income as reported for the year ended December 31, 2006 was $48.9 million and as revised was $52.0 million. The company will correct the presentation of comprehensive income in its Annual Report on Form 10-K to be filed for the year ending December 31, 2007. This correction has no effect on net income, shareholders’ equity or accumulated other comprehensive loss as previously reported at December 31, 2006.

 

4. Acquisitions

McKesson Acute-Care Business

Effective September 30, 2006, the company acquired certain assets, including inventory, fixed assets and customer contracts, and assumed certain liabilities, including lease obligations, related to the acute-care medical and surgical supply distribution business of McKesson Medical-Surgical Inc. (McKesson), a wholly-owned subsidiary of McKesson Corporation. McKesson and the company entered into a transition services agreement pursuant to which McKesson provided ongoing operational support of the business during the transition period. This transition period ended in March 2007, after which the company has no further obligation for transition service fees pursuant to the transition services agreement.

The adjusted purchase price was approximately $169.7 million in cash, including transaction costs, and is subject to further adjustment upon a final determination of the value of inventory transferred. The acquisition was financed with borrowings under

 

6


Table of Contents

the company’s revolving credit facility and cash on hand. The following table presents the adjusted preliminary purchase allocation of the estimated fair value of the assets acquired and liabilities assumed:

 

(in thousands)     

Purchase Allocation

  

Assets acquired

  

Inventory

   $ 123,744

Fixed assets

     1,511

Other current assets

     405

Intangible assets

     30,800

Goodwill

     15,935

Other non-current assets

     465
      

Total Assets Acquired

     172,860
      

Liabilities assumed

  

Current liabilities

     3,141
      

Total Liabilities Assumed

     3,141
      

Net Assets Acquired

   $ 169,719
      

The acquisition is being accounted for as a business combination in accordance with SFAS 141, Business Combinations, and, as such, the acquired assets and liabilities are recorded based on their estimated fair values as of the closing date. The allocation of the purchase price will be finalized in the third quarter of 2007, after the valuation of certain assets and liabilities is complete.

The following unaudited pro forma information assumes that the company and the acquired business were combined at the beginning of the periods presented. The data is presented for informational purposes only and does not purport to be indicative of the results that would have been achieved if the acquisition had occurred at the beginning of the periods presented. The data does not reflect operating efficiencies expected to be realized from the combined operations nor is it indicative of future operating performance.

 

(in thousands, except per share data)    Three Months Ended
June 30, 2006
  

Six Months Ended

June 30, 2006

Revenue

   $ 1,599,386    $ 3,126,240

Net income

   $ 5,107    $ 15,443

Basic earnings per share

   $ 0.13    $ 0.39

Diluted earnings per share

   $ 0.13    $ 0.38

The unaudited pro forma amounts above include estimated adjustments for amortization of acquired intangible assets, depreciation of acquired fixed assets, and interest expense on borrowings and loss of interest income on cash balances used to fund the purchase price, assuming the acquisition occurred as of the beginning of the periods presented. Interest expense has been calculated at the company’s borrowing rate under its credit facility based on rates available to the company during the periods presented. The unaudited pro forma net earnings above assume an income tax provision at the company’s consolidated tax rate for the periods presented.

Direct-to-Consumer Distribution Business

The company entered the direct-to-consumer (DTC) distribution business in January 2005, and since that date, has completed a series of acquisitions in the DTC distribution business. For the three-month periods ended June 30, 2007 and 2006, the DTC distribution business contributed $27.9 million and $21.2 million of revenue, and $2.3 million and $0.3 million of operating

 

7


Table of Contents

earnings to the company. For the six-month periods ended June 30, 2007 and 2006, the DTC distribution business contributed $54.9 million and $39.0 million of revenue, and $1.3 million and $0.0 million of operating earnings to the company.

 

5. Direct-Response Advertising Costs

The company capitalizes the costs of direct-response advertising of its direct-to-consumer diabetic supplies that meet the capitalization requirements of American Institute of Certified Public Accountants Statement of Position 93-7, Reporting on Advertising Costs. At June 30, 2007 and December 31, 2006, deferred advertising costs of $10.7 million and $9.8 million, net of accumulated amortization of $7.6 million and $4.1 million, were included in other assets, net, in the company’s condensed consolidated balance sheets. The company recorded amortization of $1.9 million in the second quarter and $3.5 million in the first six months of 2007, and recorded amortization of $0.7 million and $1.2 million in the comparable periods of 2006.

 

6. Goodwill and Intangible Assets

The following table presents the activity in goodwill for the six months ended June 30, 2007:

 

(in thousands)       

Balance, December 31, 2006

   $ 259,670  

Purchase accounting adjustments

     (629 )
        

Ending Balance

   $ 259,041  
        

Intangible assets at June 30, 2007 and December 31, 2006, are as follows:

 

(in thousands)                         
  

Weighted
average
useful
life

   June 30, 2007    December 31, 2006
      Gross
amount
   Accumulated
amortization
   Gross
amount
   Accumulated
amortization

Customer relationships

   9 years    $ 57,076    $ 17,765    $ 57,019    $ 12,358

Other intangibles

   6 years      9,791      2,621      9,791      1,689
                              

Total

      $ 66,867    $ 20,386    $ 66,810    $ 14,047
                              

Amortization expense for intangible assets was $3.2 million and $1.8 million for the three months ended June 30, 2007 and 2006, and $6.3 million and $3.4 million for the six months ended June 30, 2007 and 2006.

Based on the current carrying value of intangible assets subject to amortization, estimated future amortization expense is as follows: Remainder of 2007 – $5.7 million; 2008—$9.9 million; 2009—$6.7 million; 2010—$4.3 million; 2011—$2.8 million.

 

7. Debt

On January 29, 2007, the company amended its $250 million revolving credit facility, increasing its borrowing capacity by $100 million to $350 million.

 

8


Table of Contents
8. Retirement Plans

The components of net periodic pension cost of the company’s retirement plans for the three months and six months ended June 30, 2007 and 2006, are as follows:

 

(in thousands)   

Three Months Ended

June 30,

     Six Months Ended
June 30,
 
   2007     2006      2007     2006  

Service cost

   $ 197     $ 215      $ 424     $ 429  

Interest cost

     776       766        1,573       1,532  

Expected return on plan assets

     (422 )     (417 )      (881 )     (812 )

Amortization of prior service cost

     39       40        79       79  

Recognized net actuarial loss

     187       262        379       544  
                                 

Net periodic pension cost

   $ 777     $ 866      $ 1,574     $ 1,772  
                                 

 

9. Comprehensive Income

The company’s comprehensive income for the three months and six months ended June 30, 2007 and 2006, is shown in the table below:

 

(in thousands)   

Three Months Ended

June 30,

    Six Months Ended
June 30,
 
   2007     2006     2007     2006  

Net income

   $ 18,266     $ 10,489     $ 29,081     $ 26,992  

Other comprehensive income – change in value of cash-flow hedge derivatives, net of tax

     (12 )     (5 )     (25 )     501  

Reclassification of gain on cash-flow hedge derivative to net income, net of tax

     —         (12 )     —         (12 )
                                

Comprehensive income

   $ 18,254     $ 10,472     $ 29,056     $ 27,481  
                                

 

10. Net Income per Common Share

The following sets forth the computation of basic and diluted net income per common share:

 

(in thousands, except per share data)   

Three Months Ended

June 30,

   Six Months Ended
June 30,
   2007    2006    2007    2006

Numerator:

           

Numerator for basic and diluted net income per common share – net income

   $ 18,266    $ 10,489    $ 29,081    $ 26,992

Denominator:

           

Denominator for basic net income per common share – weighted average shares

     40,213      39,862      40,111      39,797

Effect of dilutive securities – stock options and restricted stock

     550      481      599      511
                           

Denominator for diluted net income common share – adjusted weighted average shares

     40,763      40,343      40,710      40,308
                           

Net income per common share – basic

   $ 0.45    $ 0.26    $ 0.73    $ 0.68

Net income per common share – diluted

   $ 0.45    $ 0.26    $ 0.71    $ 0.67

 

11. Adoption of FASB Interpretation No. 48

The company adopted the provisions of FASB Interpretation No. (FIN) 48, Accounting for Uncertainty in Income Taxes, on January 1, 2007. As a result of the implementation of FIN 48, the company recognized a decrease of approximately $0.8 million in its liability for unrecognized tax benefits, which was accounted for as an increase to the January 1, 2007 balance of retained earnings. At January 1, 2007, the liability for unrecognized tax benefits was approximately $25.4 million (excluding the deferred tax asset of $3.4 million associated with this liability).

 

9


Table of Contents

Included in the balance at January 1, 2007, were $18.1 million of tax positions (excluding the deferred tax asset of $0.9 million associated with these positions) for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. These tax positions are temporary differences that do not impact the annual effective tax rate under deferred tax accounting. Any change in the deductibility period of these tax positions would impact the timing of cash payments to taxing jurisdictions. The remaining $7.3 million of unrecognized tax benefits (excluding the deferred tax asset of $2.5 million associated with this liability) would impact the company’s effective tax rate, if recognized.

Included in the net balance of unrecognized tax benefits at January 1, 2007, was $2.5 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during 2007. This amount represents a possible decrease in unrecognized tax benefits comprised of items related to the settlement of ongoing audits or the expiration of statutes to assess tax.

The company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The amount of interest accrued at January 1, 2007, was $3.4 million (excluding the deferred tax asset of $1.4 million associated with this liability), which is included in the $25.4 million liability for unrecognized tax benefits noted above. There were no penalties accrued at January 1, 2007.

The company is subject to examination for federal and state purposes for the tax years 2001 through 2006, except the 2002 tax year, which is closed for federal purposes. The company has no tax years open prior to 2001.

 

12. Legal Proceedings

In September 2004, the company received a notice from the Internal Revenue Service (IRS) proposing to disallow, effective for the 2001 tax year and all subsequent years, certain reductions in the company’s tax-basis last-in, first-out (LIFO) inventory valuation. The proposed adjustment involves the timing of deductions. Management believes that its tax-basis method of LIFO inventory valuation is consistent with a ruling received by the company on this matter from the IRS and is appropriate under the tax law. The company filed an appeal with the IRS in December 2004 and plans to contest the proposed adjustment pursuant to all applicable administrative and legal procedures. If the company were unsuccessful, the adjustment would be effective for the 2001 tax year and all subsequent years, and the company would have to pay a deficiency of approximately $71.5 million in federal, state and local taxes for tax years through 2006 on which deferred taxes have been provided, as well as interest calculated at statutory rates, of approximately $11.9 million as of June 30, 2007, net of any tax benefits, for which no reserve has been established. No penalties have been proposed. The payment of the deficiency and interest would adversely affect operating cash flow for the full amount of the payment, while the company’s net income and earnings per share would be reduced by the amount of any liability for interest, net of tax. The ultimate resolution of this matter may take several years, and a determination adverse to the company could have a material effect on the company’s cash flows and results of operations.

 

10


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis describes material changes in the financial condition of Owens & Minor, Inc. and its wholly-owned subsidiaries (O&M or the company) since December 31, 2006. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto and management’s discussion and analysis of financial condition and results of operations included in the company’s Annual Report on Form 10-K for the year ended December 31, 2006.

Reclassifications

The company made changes to the presentation of its income statement effective January 1, 2007, by including amortization of direct-response advertising costs in selling, general and administrative expense. This expense was previously included in depreciation and amortization. All prior period amounts have been reclassified in order to conform to the current period presentation. This reclassification has no effect on revenue or net income as previously reported.

Results of Operations

Second quarter and first six months of 2007 compared with 2006

Overview. In the second quarter and first six months of 2007, the company earned net income of $18.3 million and $29.1 million, improved from $10.5 million and $27.0 million in the comparable periods of 2006. Net income per diluted common share was $0.45 for the second quarter and $0.71 for the first six months of 2007, increased from $0.26 and $0.67 in the comparable periods of 2006. For comparative purposes, 2006 second quarter results included a pre-tax charge of $11.4 million related to the early retirement of debt, as the company refinanced $200 million in debt at a more favorable rate. Operating earnings, which were $36.7 million in the second quarter 2007, increased from $31.2 million in the second quarter 2006, while operating earnings of $61.5 million in the first six months of 2007 decreased slightly from $61.7 million in the comparable period of 2006. The first six-month period of 2007 includes dilution estimated to be approximately $8.1 million related to the acquisition of the acute-care distribution business of McKesson Medical-Surgical Inc. Dilution, as defined by the company, represents the pre-tax net loss from the acquired acute-care distribution business.

Acquisitions. Effective September 30, 2006, the company acquired certain assets of the acute-care medical and surgical supply distribution business of McKesson Medical-Surgical Inc. (McKesson), a subsidiary of McKesson Corporation. The adjusted purchase price, including transaction costs, was approximately $169.7 million. The acquisition included inventory estimated at $123.7 million, acute-care customer relationships, certain fixed assets, and the assumption of facility leases. The purchase price is subject to adjustment upon a final determination of the value of inventory transferred, which the company believes will result in a reduction in the purchase price. The acquisition was financed under the company’s revolving credit facility, as well as cash on-hand. In connection with the acquisition, the company recorded $3.1 million of estimated involuntary termination and lease-exit costs identified to date.

Since entering the direct-to-consumer (DTC) distribution business in January 2005, the company made supplemental acquisitions of seven DTC distributors for a total of $22.7 million. These acquisitions were of stock or of certain assets consisting primarily of customer relationships. The DTC distribution business benefits from significantly higher gross margins, but also experiences higher selling, general and administrative (SG&A) expenses as a percent of revenue than the company’s acute-care supply distribution business. In the second quarter and first six months of 2007, DTC revenue was $27.9 million and $54.9 million, comparing favorably

 

11


Table of Contents

to revenue of $21.2 million and $39.0 million in the comparable periods of 2006. The company reports DTC revenue net of an estimate of contractual allowance to third-party payors. The contractual allowance was $2.4 million and $4.8 million in the second quarter and first six months of 2007, compared to $0.9 million and $1.6 million in the comparable periods of 2006. The increase was due, in part, to the combined effect of lower expected reimbursements and a gradual shift in payor mix. For the second quarter of 2007, the company reported approximately 185,000 individual customers, compared to 151,000 customers in the second quarter of 2006, an increase of 22.5%. Operating earnings for the DTC distribution business were $2.3 million and $1.3 million in the second quarter and first six months of 2007, comparing favorably to $0.3 million and $0.0 in the same periods of 2006. Factors contributing to the improved 2007 year-to-date DTC operating earnings included the cessation of costs associated with the transition to a new management team, facilities consolidation, and improved processes for billing, collections and shipping.

Revenue. Revenue increased 29.1%, or $378.7 million, to $1.68 billion in the second quarter of 2007, from $1.30 billion in the second quarter of 2006. For the first six months of 2007, revenue increased 31.3%, or $802.9 million, over the comparable period in 2006. For the quarter, the acquired McKesson business contributed $261.1 million in revenue; while for the year-to-date period, the acquired business contributed $543.6 million to revenue. The acquired McKesson business represented nearly 70% of the revenue increase in both periods, while the remainder of the increase resulted primarily from greater sales to existing customers.

Operating earnings. When compared to the second quarter of 2006, operating earnings in the second quarter of 2007 increased $5.5 million to $36.7 million. However, operating earnings decreased slightly to $61.5 million in the first six months of 2007, compared to $61.7 million in the first six months of 2006. Operating earnings improvement for the DTC distribution business represented $2.0 million and $1.3 million of the $5.5 million increase and the negative $0.2 million difference between the respective periods. As a percent of revenue, operating earnings were 2.2% in the second quarter and 1.8% in the first six months of 2007, as compared with 2.4% in the comparable periods of 2006. Operating earnings in the first six months of 2007 were negatively affected by the impact of the transition of the acquired McKesson business.

Gross margin as a percentage of revenue was 10.5% for the second quarter and 10.4% for the first six months of 2007, down from 10.9% and 10.8% in the comparable periods of 2006. These decreases resulted primarily from contract renewals with major group purchasing organizations, as well as increased sales to existing customers under these and other contracts. Under provisions of certain contracts, the company offers more favorable pricing to customers as they purchase in greater volume.

SG&A expenses were 7.9% of revenue in the second quarter and 8.2% in the first six months of 2007 as compared with 8.1% in the comparable periods of 2006. The second quarter 2007 improvement, when compared to the same period in 2006, resulted primarily from the company leveraging its infrastructure over higher sales volume. The comparative increase in SG&A expenses as a percentage of revenue in the first six months of 2007 resulted primarily from costs associated with the integration of the acquired McKesson business, including approximately $7 million in service fees paid to McKesson for operational support during the transition period. Other factors also contributed to the comparative increase in the year-to-date SG&A expenses as a percent of revenue. These included the additional costs of converting customers and their contracts to O&M’s systems, and increases in the allowance for doubtful accounts of $5.3 million, as compared with $3.3 million in the same period of 2006. The increase in the allowance for doubtful

 

12


Table of Contents

accounts was primarily related to certain customers from the acquired McKesson business.

Depreciation and amortization expense for the second quarter and first six months of 2007 was $8.1 million and $16.3 million, an increase of $2.6 million and $5.6 million from the comparable periods of 2006. These increases were driven primarily by an increase in the amortization of intangibles, resulting from acquisitions, of $1.4 million for the second quarter and $2.9 million for the first six months of 2007. The remainder of the increase resulted from greater depreciation expense resulting from: capital additions to accommodate the acquired McKesson business, construction of the company’s headquarters facility completed during the first quarter of 2006, and certain information technology assets pursuant to an amended outsourcing agreement effective during the third quarter of 2006.

Interest expense, net. Net interest expense was $6.6 million for the second quarter and $13.8 million for the first half of 2007, an increase from $2.3 million in the second quarter and $5.4 million in the first six months of 2006. These increases were due to funding the McKesson acquisition with cash and bank financing. Interest expense, net, also increased due to lower cash and cash equivalents balances available for investing.

Income taxes. The provision for income taxes was $11.8 million and $18.6 million in the second quarter and first six months of 2007, compared with $7.0 million and $17.8 million in the same periods of 2006. The effective tax rate was 39.3% and 39.0% for the second quarter and first half of 2007, compared to 40.0% and 39.8% in the same periods of 2006. The lower effective rates were primarily due to adjustments to the company’s liability for unrecognized tax benefits for resolution of outstanding tax issues and other adjustments to the tax provision.

Second quarter of 2007 compared with first quarter of 2007

Overview. In the second quarter of 2007, the company earned net income of $18.3 million, improved from $10.8 million in the first quarter of 2007. Net income per diluted common share was $0.45 for the second quarter of 2007, improved from $0.27 in the first quarter of 2007. These increases resulted from a number of factors, including: sequential improvement in gross margin to 10.5% in the second quarter from 10.4% in the first quarter; a decrease in SG&A expenses as a percentage of revenue to 7.9% in the second quarter from 8.5% in the first quarter. Second quarter gross margin results were driven by improvements in the accuracy of pricing files of customers obtained in the McKesson acquisition, and improvements in cash discounts and vendor incentives as the company resumed purchasing inventory through normal channels. SG&A improvements resulted primarily from the lower spending associated with the integration of the acquired McKesson business, as well as first quarter increases in the allowance for doubtful accounts of $1.6 million related primarily to the acquired McKesson business. Another factor in the second quarter improvement was a $2.3 million contribution to operating earnings from the DTC distribution business, compared to an operating loss of $1.0 million in the first quarter of 2007. Additionally, interest expense, net, decreased from $7.2 million in the first quarter to $6.6 million in the second quarter, as the company paid down a portion of its revolving credit facility during the quarter. Strong operating cash flows, resulting from improved asset management in the second quarter, allowed the company to reduce debt.

 

13


Table of Contents

Financial Condition, Liquidity and Capital Resources

Liquidity. In the first six months of 2007, cash and cash equivalents decreased slightly by $0.7 million to $4.4 million at June 30, 2007. In the first six months of 2007, the company generated $86.4 million of cash flow from operations, compared with $42.1 million in the first half of 2006. Cash flows in the first six months of 2007 were positively affected by reductions in accounts receivable and inventories, while cash flows in the first six months of 2006 were negatively affected by both of these items. Cash flows in the first six months of 2006 were positively affected by increases in accounts payable. Strong operating cash flow in the first half of 2007 resulted from improved asset management as the company completed the transition of the acquired McKesson business. Cash used for investing activities decreased from $17.5 million in the first six months of 2006 to $15.1 million in the first half of 2007, primarily because the company made no acquisitions during this period. Capital expenditures were $13.0 million in the first six months of 2007, compared with $11.2 million in the first half of 2006. Cash used in financing activities increased from $22.4 million in the first six months of 2006 to $71.9 million in the same period of 2007; the primary use was net payments on the company’s revolving credit facility of $59.8 million.

Accounts receivable days sales outstanding (DSO) at June 30, 2007, were 28.0 days, improved from 30.5 days at December 31, 2006, but up from 24.9 days at June 30, 2006. Inventory turnover declined to 9.4 in the second quarter of 2007 from 10.1 in the second quarter of 2006, but improved from 9.2 in the fourth quarter of 2006. When compared to the second quarter of 2006, both DSO and inventory turnover in the second quarter of 2007 were negatively affected by the acquired McKesson business, but both measurements improved from the fourth quarter of 2006. After completing the transition of the acquired McKesson business, the company began to realize improvements in asset management measurements.

In the second quarter of 2006, the company issued $200 million of 6.35% Senior Notes maturing April 15, 2016 (Senior Notes). The net proceeds from the Senior Notes, together with available cash, were used to retire substantially all of the company’s $200 million of 8 1/2% Senior Subordinated Notes. Interest on the Senior Notes is paid semiannually on April 15 and October 15. The company received an investment grade rating of “BBB-” from Fitch Ratings for the new Senior Notes and an investment grade rating of “BBB-” from Standard & Poor’s, consistent with its existing corporate credit rating, and a rating of “Ba2” from Moody’s.

In conjunction with the Senior Notes, the company entered into interest rate swap agreements in April 2006, under which the company pays counterparties a variable rate based on the London Interbank Offered Rate (LIBOR), and the counterparties pay the company a fixed interest rate of 6.35% on a notional amount of $100 million, effectively converting one-half of the notes to variable-rate debt. These swaps were designated as fair value hedges and were assumed to have no ineffectiveness under the provisions of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities.

The company believes its available financing sources will be sufficient to fund working capital needs and long-term strategic growth, although this cannot be assured. At June 30, 2007, the company had $167.6 million of available credit under its revolving credit facility.

 

14


Table of Contents

Forward-looking Statements

Certain statements in this discussion constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Although O&M believes its expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks, including, but not limited to:

 

   

general economic and business conditions;

 

   

the ability of the company to implement its strategic initiatives;

 

   

dependence on sales to certain customers;

 

   

the ability of customers to meet financial commitments due to the company;

 

   

the ability to retain existing customers and the success of marketing and other programs in attracting new customers;

 

   

dependence on suppliers;

 

   

the ability to adapt to changes in product pricing and other terms of purchase by suppliers of product;

 

   

changes in manufacturer preferences between direct sales and wholesale distribution;

 

   

competition;

 

   

changing trends in customer profiles and ordering patterns;

 

   

the ability of the company to meet customer demand for additional value-added services;

 

   

the availability of supplier incentives;

 

   

access to special inventory buying opportunities;

 

   

the ability of business partners to perform their contractual responsibilities;

 

   

the ability to manage operating expenses;

 

   

the effect of higher fuel prices on delivery costs;

 

15


Table of Contents
   

the ability of the company to manage financing costs and interest rate risk;

 

   

the risk that a decline in business volume or profitability could result in an impairment of goodwill;

 

   

the ability to timely or adequately respond to technological advances in the medical supply industry;

 

   

the ability to successfully identify, manage or integrate acquisitions;

 

   

the costs associated with and outcome of outstanding and any future litigation, including product and professional liability claims;

 

   

the outcome of outstanding tax contingencies;

 

   

the ability to manage reimbursements from Medicare, Medicaid, private healthcare insurers and individual customers;

 

   

changes in government regulations, including healthcare laws and regulations; and

 

   

changes in reimbursement guidelines of Medicare and Medicaid and/or reimbursement practices of private healthcare insurers.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

O&M provides credit, in the normal course of business, to its customers. The company performs ongoing credit evaluations of its customers and maintains reserves for credit losses.

The company is exposed to market risk from changes in interest rates related to its revolving credit facility. On January 29, 2007, the company amended its revolving credit facility to increase the aggregate commitment amount by $100 million to $350 million. As of June 30, 2007, the company had $100 million of interest rate swaps under which the company pays counterparties a variable rate based on LIBOR, and the counterparties pay the company a fixed interest rate of 6.35% on a notional amount of $100 million. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $1.0 million per year in connection with the swaps. The company had $169.3 million of outstanding borrowings under its revolving credit facility at June 30, 2007. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $0.1 million per year for every $10 million of outstanding borrowings under the revolving credit facility.

 

Item 4. Controls and Procedures

The company carried out an evaluation, with the participation of the company’s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the company’s disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the company’s disclosure controls and procedures are effective in

 

16


Table of Contents

timely alerting them to material information relating to the company required to be included in the company’s periodic SEC filings. There has been no change in the company’s internal controls over financial reporting during the quarter ended June 30, 2007, that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting.

Part II. Other Information

 

Item 1. Legal Proceedings

Certain legal proceedings pending against the company are described in the company’s Annual Report on Form 10-K for the year ended December 31, 2006. Through June 30, 2007, there have been no material developments in any legal proceedings reported in such Annual Report.

 

Item 1A. Certain Risk Factors

Certain risk factors that the company believes could affect its business and prospects are described in the company’s Annual Report on Form 10-K for the year ended December 31, 2006. Through June 30, 2007, there have been no material changes in any risk factors reported in such Annual Report.

 

Item 4. Submission of Matters to a Vote of Shareholders

The following matters were submitted to a vote of O&M’s shareholders at its annual meeting held on April 27, 2007, with the voting results designated below for each such matter:

 

(1) Election of A. Marshall Acuff, Jr. and Anne Marie Whittemore, as directors of O&M for a three-year term.

 

Directors

   Votes For   

Votes Against

Or Withheld

   Abstentions   

Broker

Non-Votes

A. Marshall Acuff, Jr.

   38,156,105    120,126    0    0

Anne Marie Whittemore

   35,717,104    2,559,127    0    0

 

(2) Approval of Owens & Minor, Inc. 2007 Teammate Stock Purchase Plan.

 

Votes For

   Votes Against Or Withheld    Abstentions   

Broker

Non-Votes

34,029,590

   161,581    826,643    3,258,417

 

(3) Ratification of the appointment of KPMG LLP as O&M’s independent registered public accountants for 2007.

 

Votes For

   Votes Against Or Withheld    Abstentions   

Broker

Non-Votes

38,170,053

   86,042    20,136    0

 

17


Table of Contents
Item 6. Exhibits.

 

(a) Exhibits

 

31.1   Certification of Chief Executive Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Chief Financial Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

18


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

     Owens & Minor, Inc.
     (Registrant)

Date

   August 7, 2007  

/s/ CRAIG R. SMITH

     Craig R. Smith
     President and Chief Executive Officer

Date

   August 7, 2007  

/s/ JAMES L. BIERMAN

     James L. Bierman
     Senior Vice President & Chief Financial Officer

Date

   August 7, 2007  

/s/ OLWEN B. CAPE

     Olwen B. Cape
    

Vice President & Controller

Chief Accounting Officer


Table of Contents

Exhibits Filed with SEC

 

Exhibit #    
31.1   Certification of Chief Executive Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Chief Financial Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

20